Gujarat Themis Biosyn Limited has reported a passive dilution of promoter shareholding to 59.33% following a Qualified Institutions Placement (QIP). The company allotted over 2.11 crore equity shares to institutional investors, increasing the total share capital base. While the promoter group’s absolute share count remains unchanged at 7.72 crore shares, their percentage stake has decreased due to the expanded equity base. The filing also disclosed that a promoter group entity holds an indirect encumbrance on 39.37% of the total share capital.
Gujarat Themis Biosyn Promoter Stake Dilutes After QIP
Total Equity Shares: 13,01,51,705 | Promoter Stake: 59.33%
Reader Takeaway: Promoter holding diluted due to QIP capital expansion; absolute share count remains stable for the group.
What just happened
Gujarat Themis Biosyn has completed a Qualified Institutions Placement (QIP), resulting in the allotment of 2,11,86,440 new equity shares on August 28, 2026. This capital raise expanded the company's total equity capital base from 10,89,65,265 shares to 13,01,51,705 shares.
Why this matters
The increase in total shares led to a passive dilution of the promoter group's percentage stake, which now stands at 59.33%. It is critical to note that the promoter group did not sell any shares in the secondary market; their total count of 7,72,18,083 shares remains exactly the same as it was before the QIP.
Encumbrance Disclosure
The filing highlighted that Pharmaceutical Business Group India Ltd, a part of the promoter group, maintains an indirect encumbrance on 5,12,40,000 shares. This represents 39.37% of the current total share capital of the company. Investors should monitor this pledged portion as it represents a significant portion of the promoter's total equity holdings.
What to track next
Shareholders should monitor future filings for any changes in the status of the indirect encumbrance or further shifts in the capital structure. The dilution is a direct consequence of the company's growth-focused fund-raising activities via QIP.